Jennifer Ruddock | Senior Vice President, Strategy and Corporate Affairs |
Howard Robin | President and Chief Executive Officer |
Dimitry Nuyten | Senior Vice President and Chief Medical Officer |
Jonathan Zalevsky | Chief Research and Development Officer |
Gil Labrucherie | Chief Operating Officer and Chief Financial Officer |
Chris Shibutani | Goldman Sachs |
Jay Olson | Oppenheimer |
Greg Harrison | Bank of America |
Andy Hsieh | William Blair |
Good day, and thank you for standing by. Welcome to the Nektar Therapeutics Third Quarter 2021 Financial Results Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Jennifer Ruddock, Head of Corporate Affairs. Please go ahead.
Thank you, Crystal, and good afternoon, everyone.